SPATA18 and neoplasm: MIEAP has been shown to act as a tumor suppressor in breast, gastric and esophageal cancers by preserving mitochondrial integrity and reducing reactive oxygen species (ROS) production, which is associated with DNA damage and mutagenesis (73, 74).